Newsletters have taken to hiring spokespeople for their promo videos, trying to give them that extra flash of veritas and professionalism and a nice “anchor voice”, and this time it’s actress and former journalist Suzanne Sena that Money Morning brings in to pitch their “super vaccine” idea… which doesn’t mean anything about the stock, of […]
Articles
New high-end biotech service from Michael Robinson, who also edits the tech and biotech-focused Nexus-9 and Nova-X newsletters. Launched during the biotech boom caused by the COVID-19 pandemic, aims to produce a new recommendation every week, and focus on world-changing biotech innovations.
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
Is C-V2X on the US Stock exchange? My online brokerage account can't find it....
ZippyD -- wanted to point out that there is a lot of promise with " Brilacidin by Innovation Pharmaceuticals ", they ar...